The Board of Directors has recommended a final dividend of ₹3.50 per equity share (i.e., 35%) for the year ended March 31, 2026.
The total dividend payout, subject to shareholder approval at the AGM, amounts to ₹11,726.75 thousand.
The Board decided not to transfer any amount to Reserves for the year under review.
Operational and Strategic Highlights
The company operates an integrated healthcare facility in Kolkata, including clinics, outpatient services, a diagnostic lab, indoor wards, ICU, surgical infrastructure, and newly commenced dialysis services.
Operations were impacted by input cost inflation linked to higher crude oil prices and a weaker rupee, stemming from global tensions (Iran-US conflict).
A change in the West Bengal State Government post-assembly elections was noted, with potential future implications for state health policy yet to be clear.
The company remains debt-free and highlights its consistent dividend payout history, interrupted only during the pandemic years.
Priorities for FY 2026-27 include strengthening outpatient and diagnostic services and expanding digital-health and geriatric-care offerings.
Corporate Governance & Compliance
Statutory Auditors: M. R. Singhwi & Co., Chartered Accountants (Firm Regn. No. 312121E). They issued an unqualified audit report.
Secretarial Auditors: S. Rath & Company, Practicing Company Secretaries. Their report contained no qualifications, reservations, or adverse remarks.
Board Composition: 4 Directors (2 Independent, 1 Executive Promoter, 1 Non-Executive Promoter). Mr. Rajesh Goenka retires by rotation and is eligible for re-appointment.
Key Managerial Personnel (KMP): Mr. Rajesh Goenka (Chairman & Whole-time Director), Mr. Santosh Kumar Thakur (CFO), Mrs. Bratati Bhattacharya (Company Secretary, appointed w.e.f June 8, 2025, replacing Mr. Dipak Kumar Shaw).
Four Board meetings and four Audit Committee meetings were held during the year.
The company has no subsidiaries, joint ventures, or associate companies.
Share Capital & Investor Relations
No change in the issued, subscribed, and paid-up share capital during the year.
99.46% of the total share capital (3,332,496 shares) is held in dematerialized form.
The company does not have any shares in a demat suspense account or unclaimed suspense account.
During the year, ₹33,541 of unpaid/unclaimed dividends and 552 shares were transferred to the Investor Education and Protection Fund (IEPF) Authority.
The company offers a 15% discount on diagnostic services to all shareholders.
Corporate Social Responsibility (CSR)
The company allocated ₹16.13 lakhs for CSR activities based on 2% of the average net profit of the last three years.
The amount was spent through implementing agency SAI BABA SEVASHRAM & YOGA RESEARCH (CSR00093999) on providing free meals, education, vocational training, and medical aid to underprivileged children in Kolkata.
No CSR Committee was constituted as the amount required to be spent did not exceed ₹50 Lakhs; functions were discharged by the Board of Directors.
Significant Orders and Material Changes
There are no significant material orders passed by regulators or courts impacting the going concern status.
There have been no material changes or commitments affecting the financial position between the year-end (March 31, 2026) and the date of the report (May 28, 2026).
Annual General Meeting (AGM)
The 32nd AGM is scheduled to be held on Saturday, September 26, 2026, at 10:30 AM IST through Video Conference/Other Audio Visual Means.
The business includes adoption of financial statements, declaration of dividend, and re-appointment of Mr. Rajesh Goenka as Director.
The Book Closure period is from September 20, 2026, to September 26, 2026 (both days inclusive).
Auditors' Key Comments
The auditors reported that the company has adequate internal financial controls systems in place.
No fraud was reported by the auditors or secretarial auditor.
The company has not accepted any deposits from the public.
